24 versus 48 Weeks of Peginterferon Plus Ribavirin in Hepatitis C Virus Genotype 6 Chronically Infected Patients with a Rapid Virological Response: A Non-Inferiority Randomized Controlled Trial-Reference-Cited by-同舟云学术

24 versus 48 Weeks of Peginterferon Plus Ribavirin in Hepatitis C Virus Genotype 6 Chronically Infected Patients with a Rapid Virological Response: A Non-Inferiority Randomized Controlled Trial

Published:2015-10-28 Issue:10 Volume:10 Page:e0140853
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Cai Qingxian,Zhang Xiaohong,Lin Chaoshuang,Shao Xiaoqiong,Guan Yujuan,Deng Hong,Wei Min,Huang Mingshou,Ren Zefang,Lu Ling,Mei Yongyu,Xu Min,Zhu Jianyun,Shi Haiyan,Lin Guoli,Liu Ying,Hu Fengyu,Luo Qiumin,Lan Yun,Guo Fengxia,Zhao Zhixin,Gao Zhiliang

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference52 articles.

1. Global epidemiology and genotype distribution of the hepatitis C virus infection;E Gower;J Hepatol,2014

2. Course and outcome of hepatitis C;JH Hoofnagle;Hepatology,2002

3. Clinical consequences of hepatitis C virus infection;F Zoulim;Rev Med Virol,2003

4. Response to letter to the editor: Strategies to reduce HCV disease burden and HCV transmission need different models, as what works for end-stage liver disease may not work for HCV prevalence: a comment on the results presented in JVH Special Issue;H Razavi;J Viral Hepat,2014

5. ICTVOnline website. Available: http://talk.ictvonline.org/ictv_wikis/w/sg_flavi/35.table-1-confirmed-hcv-genotypessubtypes-november-2014.aspx

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and efficacy of sofosbuvir-based direct-acting antiviral regimens for hepatitis C virus genotype 6 in Southwest China: Real-world experience of a retrospective study;Journal of Viral Hepatitis;2018-12-03

2. Clinical Characteristics and Treatment Outcome of Peginterferon Plus Ribavirin in Patients Infected with Genotype 6 Hepatitis C Virus in Korea: A Multicenter Study;Gut and Liver;2017-03-15